Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Previously Funded Researchers
  5. Argyrios Tzouvelekis, Ph.D.
Argyrios Tzouvelekis, Ph.D.

Argyrios Tzouvelekis, Ph.D.

Yale University

Research Project:
Enzyme Could Play Key Role in Idiopathic Pulmonary Fibrosis

Grant Awarded:

  • Senior Research Training Fellowship

Research Topic:

  • basic biologic mechanisms

Research Disease:

  • pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease in which lung tissue becomes scarred over time in response to unknown injuries. This leads to shortness of breath and dry cough that gradually progresses, culminating in death in 3-5 years. The IPF lung is characterized by increases in cells in the lung called fibroblasts. We have discovered an enzyme called SHP-2 is decreased in the lung fibroblasts of patients with IPF. We will study whether reduced levels of SHP-2 from the lungs of patients with IPF render them susceptible to disease development, and whether restoring its levels in a mouse model of lung fibrosis may exert a therapeutic role.

Page last updated: April 18, 2024

Asthma Educator Institute
, | Jul 11, 2015
See All Events